Welcome to our dedicated page for Paychex SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Paychex, Inc. (Nasdaq: PAYX) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, drawn from the U.S. Securities and Exchange Commission’s EDGAR system. As a Delaware corporation with shares listed on the Nasdaq Global Select Market, Paychex files a range of documents that give investors and analysts detailed insight into its human capital management (HCM) and payroll services business.
Among the most important filings for PAYX are its annual reports on Form 10-K and quarterly reports on Form 10-Q, which include audited or reviewed financial statements, segment information, discussion of operations, risk factors, and management’s analysis of results. These filings are central for understanding how Paychex generates revenue from cloud-based payroll and HCM software, administrative service organization and professional employer organization offerings, and retirement and insurance-related services, as described in company materials.
Investors will also find current reports on Form 8-K, which Paychex uses to furnish earnings press releases, report on significant corporate events, and provide information about transactions. Recent 8-K filings referenced in the data include results of operations for specific quarters, details of the Paycor HCM, Inc. acquisition, annual meeting voting outcomes, and changes in senior leadership roles.
The definitive proxy statement on Schedule 14A offers additional detail on corporate governance, director elections, executive compensation, and shareholder voting matters. This document can be useful for evaluating Paychex’s governance structure, compensation policies, and shareholder engagement practices.
On Stock Titan, these PAYX filings are updated in near real time as they are posted to EDGAR. AI-powered tools can help summarize lengthy documents such as 10-Ks and 10-Qs, highlight key metrics and disclosures, and surface notable items from 8-Ks, proxy materials, and other submissions. Users researching Paychex’s financial performance, acquisition activity, compensation programs, or governance can use this page as a centralized entry point to the company’s regulatory record, including any insider transaction reports (Form 4) and other relevant SEC forms as they become available.
Paychex, Inc. executive Chad C. Parodi, SVP, HCM, PEO & Insurance, reported a small disposition of company stock tied to equity compensation. On 01/15/2026, 347 shares of Paychex common stock were withheld at $110.51 per share to satisfy tax withholding obligations arising from the lapse of restrictions on restricted stock units. After this tax-related share disposition, Parodi beneficially owned 6,336 shares of Paychex common stock directly. He also held stock options exercisable for 6,775, 13,192, and 11,813 shares of common stock with exercise prices of $119.72, $121.63, and $140.68, respectively, all held directly.
Paychex, Inc. filed a current report to furnish a press release announcing its financial results for the three and six months ended November 30, 2025. The press release is included as Exhibit 99.1 and provides details on the company’s results of operations and financial condition for these periods. The information in this report and the exhibit is being furnished rather than filed, which limits how it is treated under securities law and how it may be incorporated into other regulatory documents.
Paychex (PAYX) insider reported a charitable gift of common stock. On 10/28/2025, the reporting person executed a Code G transaction, gifting 200 shares at $123.87 per share. Following the transaction, the filer beneficially owns 36,640,384 shares directly and 41,277 shares indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005. The filer is identified as a Director and filed individually.
Paychex (PAYX) director reported a charitable transfer of common stock. On 10/22/2025, the insider filed a Code G transaction indicating a gift of 302,050 shares to various non-profit organizations.
After the transaction, the filer reported 36,640,584 shares beneficially owned directly and 41,277 shares owned indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005.
Paychex Inc. (PAYX) reported an insider Form 4 for a senior vice president. On 10/15/2025, the officer disposed of 41 common shares at $127.52 under code F, which indicates shares were withheld to cover taxes from vested restricted stock units.
After the transaction, the officer beneficially owned 9,794 shares, held directly. The filing also lists vested and unvested stock options, including 12,164 shares at an exercise price of $120.86 (expiring 07/14/2033) and 14,291 shares at $121.63 (expiring 07/14/2034).
Paychex (PAYX) reported an insider equity award on Form 4. A director acquired 725 shares of common stock via restricted stock units on 10/15/2025 at $0, increasing beneficial ownership to 79,344 shares directly.
The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, first exercisable on 10/15/2026 and expiring on 10/14/2035. Existing option holdings remain outstanding across multiple grants, with exercise prices ranging from $57.20 to $140.68 and expirations extending through 2035. The RSU award is pursuant to the Amended and Restated 2002 Stock Incentive Plan.
Paychex, Inc. (PAYX) disclosed an insider equity award. A director reported acquiring 725 shares of common stock on 10/15/2025 at $0, reflecting vested or granted shares. Following the transaction, the director beneficially owned 11,770 shares directly.
The filer also received a stock option grant for 3,061 shares at an exercise price of $127.52, exercisable 10/15/2026 and expiring 10/14/2035. The filing notes the equity award includes restricted stock units subject to vesting under the company’s Amended and Restated 2002 Stock Incentive Plan.
Paychex (PAYX) reported an insider transaction by its Sr. VP & CFO. On 10/15/2025, the officer disposed of 116 shares of common stock at $127.52 under code F, a sale to cover taxes from the vesting of restricted stock units. Following the transaction, the officer beneficially owns 19,165 shares directly and 322 shares indirectly via a 401(k). The filing also lists outstanding stock options across multiple grants with various exercise prices and expirations.
Paychex (PAYX) disclosed a director’s equity awards on Form 4. The reporting person acquired 725 shares of common stock at $0, noted as restricted stock units subject to vesting. The filing also reports a new stock option grant for 3,061 shares at $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Following the transaction, 3,951 shares of common stock were beneficially owned directly.
Paychex (PAYX) filed a Form 3 reporting initial beneficial ownership by an officer. As of the event date 10/09/2025, the reporting person, an SVP, HCM, PEO & Insurance, directly owns 6,683 shares of Common Stock.
Table II lists stock options for Common Stock as follows: 6,775 shares at $119.72 exercisable on 01/15/2025 expiring 01/14/2034; 13,192 shares at $121.63 exercisable on 07/15/2025 expiring 07/14/2034; and 11,813 shares at $140.68 exercisable on 07/15/2026 expiring 07/14/2035. The filing indicates direct ownership and was signed by an attorney-in-fact.
FAQ
What is the current stock price of Paychex (PAYX)?
What is the market cap of Paychex (PAYX)?
